Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker ATRC
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 6, 2026 | B. Kristine Johnson Director | ATRC AtriCure, Inc. | Sale | 2,452 | $58.48 | $143.4K Sale | Form 4 ↗ |
| Nov 4, 2026 | Salvatore Privitera Chief Technical Officer | ATRC AtriCure, Inc. | Sale | 8,404 | $65.00 | $546.3K Sale | Form 4 ↗ |
| Sep 23, 2026 | Salvatore Privitera Chief Technical Officer | ATRC AtriCure, Inc. | Sale | 4,519 | $60.00 | $271.1K Sale | Form 4 ↗ |
| Sep 11, 2026 | Regina E. Groves Director | ATRC AtriCure, Inc. | Sale | 5,313 | $54.22 | $288.1K Sale | Form 4 ↗ |
| Sep 8, 2026 | Salvatore Privitera Chief Technical Officer | ATRC AtriCure, Inc. | Sale | 3,657 | $55.00 | $201.1K Sale | Form 4 ↗ |
| Sep 2, 2026 | Salvatore Privitera Chief Technical Officer | ATRC AtriCure, Inc. | Sale | 7,763 | $52.50 | $407.6K Sale | Form 4 ↗ |
| Aug 24, 2026 | Karl S. Dahlquist Chief Legal Officer | ATRC AtriCure, Inc. | Sale | 9,370 | $48.89 | $458.1K Sale | Form 4 ↗ |
| Aug 5, 2026 | Maggie Yuen Director | ATRC AtriCure, Inc. | Sale | 3,500 | $38.42 | $134.5K Sale | Form 4 ↗ |
| Aug 5, 2026 | Karen Prange Director | ATRC AtriCure, Inc. | Sale | 3,564 | $38.80 | $138.3K Sale | Form 4 ↗ |
| Jul 29, 2026 | Justin J. Noznesky Chief Mktg & Strategy Officer | ATRC AtriCure, Inc. | Sale | 6,182 | $38.80 | $239.9K Sale | Form 4 ↗ |
| Jul 28, 2026 | Vinayak Doraiswamy Chief Scientific Officer | ATRC AtriCure, Inc. | Sale | 6,000 | $38.88 | $233.3K Sale | Form 4 ↗ |
| Jul 28, 2026 | Sven Wehrwein Director | ATRC AtriCure, Inc. | Sale | 25,000 | $37.84 | $946.0K Sale | Form 4 ↗ |
| May 20, 2026 | Karen Prange Director | ATRC AtriCure, Inc. | Sale | 3,000 | $28.65 | $86.0K Sale | Form 4 ↗ |
| May 15, 2026 | Vinayak Doraiswamy Chief Scientific Officer | ATRC AtriCure, Inc. | Sale | 5,000 | $28.13 | $140.7K Sale | Form 4 ↗ |
| Mar 12, 2026 | Vinayak Doraiswamy Chief Scientific Officer | ATRC AtriCure, Inc. | Sale | 5,000 | $29.83 | $149.2K Sale | Form 4 ↗ |
| Nov 26, 2025 | Justin J. Noznesky Chief Mktg & Strategy Officer | ATRC AtriCure, Inc. | Sale | 5,166 | $37.29 | $192.6K Sale | Form 4 ↗ |
| Nov 25, 2025 | Sven Wehrwein Director | ATRC AtriCure, Inc. | Sale | 4,967 | $38.00 | $188.7K Sale | Form 4 ↗ |
| Nov 24, 2025 | Sven Wehrwein Director | ATRC AtriCure, Inc. | Sale | 5,033 | $37.32 | $187.8K Sale | Form 4 ↗ |
| Nov 21, 2025 | Maggie Yuen Director | ATRC AtriCure, Inc. | Sale | 3,000 | $35.72 | $107.2K Sale | Form 4 ↗ |
| Sep 12, 2025 | Justin J. Noznesky Chief Mktg & Strategy Officer | ATRC AtriCure, Inc. | Sale | 3,000 | $36.30 | $108.9K Sale | Form 4 ↗ |
| Aug 22, 2025 | Sven Wehrwein Director | ATRC AtriCure, Inc. | Sale | 5,000 | $37.00 | $185.0K Sale | Form 4 ↗ |
| Aug 19, 2025 | Sven Wehrwein Director | ATRC AtriCure, Inc. | Sale | 5,000 | $36.00 | $180.0K Sale | Form 4 ↗ |
| Aug 6, 2025 | Regina E. Groves Director | ATRC AtriCure, Inc. | Sale | 2,452 | $36.82 | $90.3K Sale | Form 4 ↗ |
| Aug 5, 2025 | Vinayak Doraiswamy Chief Scientific Officer | ATRC AtriCure, Inc. | Sale | 2,500 | $36.58 | $91.5K Sale | Form 4 ↗ |
| May 28, 2025 | Vinayak Doraiswamy Chief Scientific Officer | ATRC AtriCure, Inc. | Sale | 2,500 | $33.44 | $83.6K Sale | Form 4 ↗ |
| Mar 5, 2025 | Karen Prange Director | ATRC AtriCure, Inc. | Sale | 6,100 | $38.12 | $232.5K Sale | Form 4 ↗ |
26 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:37 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances